233 related articles for article (PubMed ID: 29463813)
1. Oligomeric proanthocyanidins (OPCs) target cancer stem-like cells and suppress tumor organoid formation in colorectal cancer.
Toden S; Ravindranathan P; Gu J; Cardenas J; Yuchang M; Goel A
Sci Rep; 2018 Feb; 8(1):3335. PubMed ID: 29463813
[TBL] [Abstract][Full Text] [Related]
2. A combination of curcumin and oligomeric proanthocyanidins offer superior anti-tumorigenic properties in colorectal cancer.
Ravindranathan P; Pasham D; Balaji U; Cardenas J; Gu J; Toden S; Goel A
Sci Rep; 2018 Sep; 8(1):13869. PubMed ID: 30218018
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic insights into anticancer properties of oligomeric proanthocyanidins from grape seeds in colorectal cancer.
Ravindranathan P; Pasham D; Balaji U; Cardenas J; Gu J; Toden S; Goel A
Carcinogenesis; 2018 May; 39(6):767-777. PubMed ID: 29684110
[TBL] [Abstract][Full Text] [Related]
4. Enhanced anti-cancer activity of andrographis with oligomeric proanthocyanidins through activation of metabolic and ferroptosis pathways in colorectal cancer.
Shimura T; Sharma P; Sharma GG; Banwait JK; Goel A
Sci Rep; 2021 Apr; 11(1):7548. PubMed ID: 33824419
[TBL] [Abstract][Full Text] [Related]
5. Oligomeric proanthocyanidins (OPCs) from grape seed extract suppress the activity of ABC transporters in overcoming chemoresistance in colorectal cancer cells.
Ravindranathan P; Pasham D; Goel A
Carcinogenesis; 2019 May; 40(3):412-421. PubMed ID: 30596962
[TBL] [Abstract][Full Text] [Related]
6. Anti-cancer activity of amorphous curcumin preparation in patient-derived colorectal cancer organoids.
Elbadawy M; Hayashi K; Ayame H; Ishihara Y; Abugomaa A; Shibutani M; Hayashi SM; Hazama S; Takenouchi H; Nakajima M; Tsunedomi R; Suzuki N; Nagano H; Shinohara Y; Kaneda M; Yamawaki H; Usui T; Sasaki K
Biomed Pharmacother; 2021 Oct; 142():112043. PubMed ID: 34411919
[TBL] [Abstract][Full Text] [Related]
7. Organoid modelling identifies that DACH1 functions as a tumour promoter in colorectal cancer by modulating BMP signalling.
Hu X; Zhang L; Li Y; Ma X; Dai W; Gao X; Rao X; Fu G; Wang R; Pan M; Guo Q; Xu X; Zhou Y; Gao J; Zhang Z; Cai S; Peng J; Hua G
EBioMedicine; 2020 Jun; 56():102800. PubMed ID: 32512510
[TBL] [Abstract][Full Text] [Related]
8. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.
Xie BY; Wu AW
Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340
[TBL] [Abstract][Full Text] [Related]
9. Silibinin suppresses the maintenance of colorectal cancer stem-like cells by inhibiting PP2A/AKT/mTOR pathways.
Wang JY; Chang CC; Chiang CC; Chen WM; Hung SC
J Cell Biochem; 2012 May; 113(5):1733-43. PubMed ID: 22213051
[TBL] [Abstract][Full Text] [Related]
10. Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer.
Leng Z; Xia Q; Chen J; Li Y; Xu J; Zhao E; Zheng H; Ai W; Dong J
Cell Physiol Biochem; 2018; 46(2):860-872. PubMed ID: 29627827
[TBL] [Abstract][Full Text] [Related]
11. Paracrine orchestration of intestinal tumorigenesis by a mesenchymal niche.
Roulis M; Kaklamanos A; Schernthanner M; Bielecki P; Zhao J; Kaffe E; Frommelt LS; Qu R; Knapp MS; Henriques A; Chalkidi N; Koliaraki V; Jiao J; Brewer JR; Bacher M; Blackburn HN; Zhao X; Breyer RM; Aidinis V; Jain D; Su B; Herschman HR; Kluger Y; Kollias G; Flavell RA
Nature; 2020 Apr; 580(7804):524-529. PubMed ID: 32322056
[TBL] [Abstract][Full Text] [Related]
12. Epigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer.
Toden S; Tran HM; Tovar-Camargo OA; Okugawa Y; Goel A
Oncotarget; 2016 Mar; 7(13):16158-71. PubMed ID: 26930714
[TBL] [Abstract][Full Text] [Related]
13. SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells.
Hwang WL; Yang MH; Tsai ML; Lan HY; Su SH; Chang SC; Teng HW; Yang SH; Lan YT; Chiou SH; Wang HW
Gastroenterology; 2011 Jul; 141(1):279-91, 291.e1-5. PubMed ID: 21640118
[TBL] [Abstract][Full Text] [Related]
14. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
[TBL] [Abstract][Full Text] [Related]
15. Berberine and Oligomeric Proanthocyanidins Exhibit Synergistic Efficacy Through Regulation of PI3K-Akt Signaling Pathway in Colorectal Cancer.
Okuno K; Garg R; Yuan YC; Tokunaga M; Kinugasa Y; Goel A
Front Oncol; 2022; 12():855860. PubMed ID: 35600365
[TBL] [Abstract][Full Text] [Related]
16. Sphere‑forming assay vs. organoid culture: Determining long‑term stemness and the chemoresistant capacity of primary colorectal cancer cells.
Zhao H; Yan C; Hu Y; Mu L; Huang K; Li Q; Li X; Tao D; Qin J
Int J Oncol; 2019 Mar; 54(3):893-904. PubMed ID: 30664193
[TBL] [Abstract][Full Text] [Related]
17. Differentiated cancer cell-originated lactate promotes the self-renewal of cancer stem cells in patient-derived colorectal cancer organoids.
Zhao H; Yan C; Hu Y; Mu L; Liu S; Huang K; Li Q; Li X; Tao D; Qin J
Cancer Lett; 2020 Nov; 493():236-244. PubMed ID: 32898601
[TBL] [Abstract][Full Text] [Related]
18. Role of CD44(high)/CD133(high) HCT-116 cells in the tumorigenesis of colon cancer.
Zhou JY; Chen M; Ma L; Wang X; Chen YG; Liu SL
Oncotarget; 2016 Feb; 7(7):7657-66. PubMed ID: 26840024
[TBL] [Abstract][Full Text] [Related]
19. FGF Signalling in the Self-Renewal of Colon Cancer Organoids.
Otte J; Dizdar L; Behrens B; Goering W; Knoefel WT; Wruck W; Stoecklein NH; Adjaye J
Sci Rep; 2019 Nov; 9(1):17365. PubMed ID: 31758153
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic heterogeneity of 2D organoid reflects clinical tumor characteristics.
Fujino S; Ito A; Ohue M; Yasui M; Mizushima T; Doki Y; Mori M; Miyoshi N
Biochem Biophys Res Commun; 2019 May; 513(2):332-339. PubMed ID: 30955861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
